Rectal Cancer
Recent findings in rectal cancer described by D.W. Dietz and colleagues
Published in Respiratory Therapeutics Week, December 22nd, 2008
"We hypothesized that imaging with the novel hypoxia-detecting agent, Cu-60-diacetyl-bis (N-4-methylthiosemicarbazone) (Cu-60-ATSM), previously validated in cervical and lung cancers, would predict the response of rectal cancers to neoadjuvant chemoradiotherapy and prognosis. Patients with locally invasive (T2-4) primary or node-positive rectal cancer located < 12 cm from the anal verge were...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Respiratory Therapeutics Week
More Articles from Respiratory Therapeutics Week
- NIH/National Heart, Lung and Blood Institute
Researchers find new genetic target for sickle cell disease therapy - Angiotensins
Research conducted at B.R. Haymore and co-authors has provided new information about angiotensins - Asthma
Research from P. Chervinsky and co-authors yields new data on asthma - Asthma
Research from Stanford University in the area of asthma published - Bristol-Myers Squibb Company
ERBITUX® Supplemental Biologics License Application for Advanced Non-Small Cell Lung Cancer Submitted to U.S. Food and Drug Administration - Community-Acquired
Research from P.G. Ambrose and co-researchers yields new findings on community-acquired - More from this issue of Respiratory Therapeutics Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
